Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease  Sandhya S. Thomas, Yanjun Dong,

Slides:



Advertisements
Similar presentations
Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease  Sandhya S. Thomas, Yanjun Dong,
Advertisements

Volume 76, Issue 7, Pages (October 2009)
Volume 68, Issue 4, Pages (October 2005)
Volume 90, Issue 1, Pages (July 2016)
The Suppressor of Cytokine Signaling-3 Is Upregulated in Impaired Skin Repair: Implications for Keratinocyte Proliferation  Itamar Goren, Andreas Linke,
High-mobility group box-1 protein induces osteogenic phenotype changes in aortic valve interstitial cells  Bo Wang, PhD, Fei Li, MD, Chao Zhang, PhD,
Volume 144, Issue 5, Pages e10 (May 2013)
Mesenchymal Stem Cells Promote Formation of Colorectal Tumors in Mice
Volume 18, Issue 3, Pages (September 2013)
Volume 78, Issue 3, Pages (August 2010)
Volume 85, Issue 2, Pages (January 2014)
TWEAK/Fn14 Activation Contributes to the Pathogenesis of Bullous Pemphigoid  Yale Liu, Lingling Peng, Liang Li, Chengfei Liu, Xiao Hu, Shengxiang Xiao,
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
IL-2–mediated apoptosis of kidney tubular epithelial cells is regulated by the caspase-8 inhibitor c-FLIP  Caigan Du, Qiunong Guan, Ziqin Yin, Robert.
Wanhong Ding, John A. Wagner, Richard D. Granstein 
Volume 69, Issue 4, Pages (February 2006)
Volume 117, Issue 3, Pages (April 2004)
Volume 90, Issue 1, Pages (July 2016)
Volume 85, Issue 2, Pages (January 2014)
Shitao Li, Lingyan Wang, Michael A. Berman, Ye Zhang, Martin E. Dorf 
Volume 35, Issue 4, Pages (October 2011)
H.T. Lee, M. Kim, M. Jan, R.B. Penn, C.W. Emala  Kidney International 
Decreased Expression of Caveolin-1 Contributes to the Pathogenesis of Psoriasiform Dermatitis in Mice  Yukie Yamaguchi, Yuko Watanabe, Tomoya Watanabe,
Volume 16, Issue 10, Pages (September 2016)
Epidermal Growth Factor Induces Fibronectin Expression in Human Dermal Fibroblasts via Protein Kinase C δ Signaling Pathway  Yoshihiro Mimura, Hironobu.
Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated.
RNA-Seq and ChIP-Seq Reveal SQSTM1/p62 as a Key Mediator of JunB Suppression of NF-κB-Dependent Inflammation  Xiaoling Zhang, Jane Y. Jin, Joseph Wu,
The C-terminus of Hsp70-Interacting Protein Promotes Met Receptor Degradation  Kang Won Jang, PhD, Jeong Eun Lee, MD, Sun Young Kim, MD, Min-Woong Kang,
UCHL1 Regulates Melanogenesis through Controlling MITF Stability in Human Melanocytes  Eun Young Seo, Seon-Pil Jin, Kyung-Cheol Sohn, Chi-Hyun Park, Dong.
Volume 14, Issue 3, Pages (May 2004)
IRS1-Independent Defects Define Major Nodes of Insulin Resistance
Andreea M. Bujor, Jaspreet Pannu, Shizhong Bu, Edwin A. Smith, Robin C
Volume 87, Issue 2, Pages (February 2015)
Volume 68, Issue 1, Pages (July 2005)
Volume 134, Issue 3, Pages (March 2008)
Volume 140, Issue 3, Pages (March 2011)
Volume 79, Issue 7, Pages (April 2011)
Volume 81, Issue 3, Pages (February 2012)
Volume 87, Issue 1, Pages (January 2015)
Volume 79, Issue 8, Pages (April 2011)
Volume 84, Issue 2, Pages (August 2013)
Volume 74, Issue 11, Pages (December 2008)
Volume 7, Issue 4, Pages (May 2014)
Volume 63, Issue 2, Pages (February 2003)
Volume 68, Issue 4, Pages (October 2005)
Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor  P.Y. Chuang, Q. Yu, W. Fang, J. Uribarri, J.C.
Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor  L.D. Alexander, Y. Ding, S. Alagarsamy,
Estrogen receptor β agonist diarylpropionitrile inhibits lipopolysaccharide-induced regulated on activation normal T cell expressed and secreted (RANTES)
Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways 
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Volume 9, Issue 5, Pages (May 2009)
Volume 6, Issue 5, Pages (November 2007)
Volume 82, Issue 4, Pages (August 2012)
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
Volume 70, Issue 4, Pages (August 2006)
Volume 76, Issue 7, Pages (October 2009)
The IL-6 Trans-Signaling-STAT3 Pathway Mediates ECM and Cellular Proliferation in Fibroblasts from Hypertrophic Scar  Sutapa Ray, Xiaoxi Ju, Hong Sun,
Volume 78, Issue 7, Pages (October 2010)
Volume 20, Issue 4, Pages (November 2005)
Volume 64, Issue 6, Pages (December 2003)
Volume 21, Issue 6, Pages (November 2017)
Amanda O'Donnell, Shen-Hsi Yang, Andrew D. Sharrocks  Molecular Cell 
Volume 129, Issue 2, Pages (April 2007)
Volume 125, Issue 4, Pages (May 2006)
Volume 83, Issue 5, Pages (November 2002)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Volume 70, Issue 5, Pages (September 2006)
Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells  S.-H. Wu, X.-H. Wu, C. Lu, L. Dong, G.-P.
P38 activation mediates chronic insulin-induced IRS1 and IRS2 degradation and is involved in myocardial insulin resistance in vitro. p38 activation mediates.
A Direct HDAC4-MAP Kinase Crosstalk Activates Muscle Atrophy Program
Presentation transcript:

Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease  Sandhya S. Thomas, Yanjun Dong, Liping Zhang, William E. Mitch  Kidney International  Volume 84, Issue 2, Pages 308-316 (August 2013) DOI: 10.1038/ki.2013.97 Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 1 Insulin resistance is present in chronic kidney disease (CKD) mice. (a) Intraperitoneal glucose tolerance test was performed in CKD versus control (CTL) mice after 16h of fast (*P<0.01 and **P<0.001 vs. CTL, n=5). (b) Intraperitoneal insulin tolerance test was performed in CKD versus CTL mice after a 4-h fast. (*P<0.05 vs. CTL, n=3). (c) Representative immunoblots from gastrocnemius muscle lysates of CKD versus CTL mice after 6h of fast and stimulation with 10U/kg of insulin, which was allowed to circulate for 5min before muscles were collected (left panel). The band density of pY-IRS-1 to insulin receptor substrate-1 (IRS-1) and pY-insulin receptor (pY-IR) to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is shown in the right panel (*P<0.05 vs. CTL, n=3). (d) Representative immunoblots of p-Akt protein from gastrocnemius muscle lysates from CKD versus control mice (left panel). The band density of p-Akt to GAPDH is shown in the right panel (*P<0.05 vs. CTL; n=3). pY, tyrosine phosphorylation. Kidney International 2013 84, 308-316DOI: (10.1038/ki.2013.97) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 2 In chronic kidney disease (CKD) muscle, signal regulatory protein-α (SIRP-α) expression is upregulated. (a) SIRP-α mRNA expression in gastrocnemius muscles of CKD versus sham-operated control (CTL) mice was evaluated by real time polymerase chain reaction. *P<0.05 versus CTL; n=3. (b) Representative immunoblots of SIRP-α protein from gastrocnemius muscle lysates from CKD versus control mice (upper panel). The band density of SIRP-α to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is shown in the lower panel (*P<0.05 vs. CTL; n=3). (c) Cross-sections of the tibialis anterior muscle from CKD versus control mice were immunostained with SIRP-α (green) or negative control (rabbit immunoglobulin G (IgG)). Scale bar=50μm. (d) In gastrocnemius muscle lysates of CKD versus CTL, insulin receptor-beta (IR-β) (top panel) and insulin receptor substrate-1 (IRS-1; middle panel) immunoprecipitates were immunblotted with SIRP- α, or proteins were immunoprecipitated (IP) for SIRP-α and immunoblotted (IB) with IRS-1, IR-β, or SIRP-α (bottom panel). Kidney International 2013 84, 308-316DOI: (10.1038/ki.2013.97) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 3 Cytokines trigger signal regulatory protein-α (SIRP-α) expression, impair insulin signaling, and activate E3 ubiquitin ligases in C2C12 myotubes. C2C12 myotubes were serum starved, and then treated with a mixture of interleukin-6 (IL-6; 2ng/ml), tumor necrosis factor-α (TNF-α; 2ng/ml), interferon-γ (IFN-γ; 2ng/ml), and lipopolysaccharide (LPS; 10ng/ml) for 6 or 24h and compared with control (CTL) myotubes without cytokine exposure. (a) Representative immunoblots were probed with p-Tyrosine-insulin receptor substrate-1 (pY-IRS-1), pY-insulin receptor (pY-IR), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; left panel). The quantitative analysis of protein expression relative to GAPDH is shown (right panel; *P<0.05 vs. CTL, n=3 independent experiments). (b) Representative immunoblots of SIRP-α and p-Akt are shown (left panel). The quantitative analysis of protein expression to GAPDH is shown (right panel; *P<0.05 vs. CTL, n=3 independent experiments). (c–e) mRNA expression of (c) SIRP-α, (c) atrogin-1, and (d) MuRF-1 were measured by real time polymerase chain reaction at 6 or 24h (*P<0.05 vs. CTL, n=3 repeats). Kidney International 2013 84, 308-316DOI: (10.1038/ki.2013.97) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 4 Overexpression of signal regulatory protein-α (SIRP-α) impairs insulin signaling and increases protein degradation. C2C12 myotubes were transfected with SIRP-α plasmid versus plasmid expressing green fluorescent protein (GFP). Cells were allowed to differentiate into myotubes, serum starved, and treated with cytokines for 30min. (a) Representative western blots of SIRP-α and p-Akt (left panel) with measured band density of protein relative to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as illustrated (right panel; *P<0.05 and **P<0.01 vs. GFP; n=3 independent experiments). (b) MuRF-1 mRNA expression was measured by real time polymerase chain reaction (**P<0.01 vs. GFP; n=3 independent experiments). (c) Rate of protein degradation was measured in cells transfected with SIRP-α plasmid or GFP plasmid. *P<0.05 versus GFP; n=3 independent experiments. Kidney International 2013 84, 308-316DOI: (10.1038/ki.2013.97) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 5 Suppression of signal regulatory protein-α (SIRP-α) improves insulin signaling and blocks protein degradation despite the presence of cytokines. (a) C2C12 myoblasts were transfected with SIRP-α siRNA (SIRP-α) versus control scrambled siRNA (CTL). siRNA, small interfering RNA. After differentiating into myotubes, cells were serum starved, and subsequently treated with cytokine mixture for 24h. Representative immunoblots of SIRP-α and p-Akt (left panel), and band density relative to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and Akt, respectively, is illustrated (right panel; *P<0.05 vs. CTL; n=3 independent experiments). (b) C2C12 myoblasts were transfected with SIRP-α siRNA (SIRP-α) versus control scrambled siRNA (CTL). Following differentiation, the myotubes were serum starved, and subsequently treated with cytokines for 6h. Subsequently, cells were washed with serum-free media and then treated with 100nm of insulin in fresh serum-free media for 5min. Representative immunoblots were probed with p-Tyrosine-insulin receptor substrate-1 (pY-IRS-1), pY-insulin receptor (pY-IR), and GAPDH (left panel). Quantitative analysis of proteins pY-IRS-1 to IRS-1 or pY-IR to GAPDH is shown (right panel; *P<0.05 vs. CTL; n=3 repeats). (c–e) With the same treatment as in a. The mRNA expression of E3 ubiquitin ligases (c) atrogin-1 and (d) MuRF-1 was measured based on real time polymerase chain reaction (*P<0.05 vs. CTL; n=3 repeats). (e) The rate of protein degradation was measured in cells transfected with SIRP-α siRNA versus CTL siRNA (*P<0.05 vs. CTL; n=3 independent experiments). Kidney International 2013 84, 308-316DOI: (10.1038/ki.2013.97) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 6 Nuclear factor (NF)-κB regulates signal regulatory protein-α (SIRP-α) expression. (a) Gastrocnemius muscle lysates were obtained from chronic kidney disease (CKD) versus control (CTL) mice. Representative immunoblots of p-IκBα as illustrated (left panel). Band density was measured relative to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as shown (right panel; *P<0.05 vs. CTL; n=3). (b) C2C12 myoblasts were infected with a NF-κB-promoter-luciferase construct. Following their differentiation, the myotubes were treated with the cytokine mixture in serum-starved media. Activation of the NF-κB promoter at times listed were measured and the fold change over 0h was quantified (*P<0.05 and **P<0.001 vs. 0h; n=4 independent experiments). (c) Serum-starved myotubes were treated with cytokine mixture with or without the NF-κB inhibitor, QNZ. Representative immunoblots of SIRP-α expression (left panel) and band density relative to GAPDH is shown (right panel; *P<0.05 vs. CTL; n=3 independent experiments). (d) C2C12 myoblasts were infected with a dominant-negative IKKβ (DNIKKβ) adenovirus or a control adenovirus that expresses green fluorescent protein (GFP). After differentiation, both cell groups were serum starved and treated with cytokines for 24h. Representative western blot analysis (left panel) with quantitative band density of IKKβ and SIRP-α relative to GAPDH is shown (right panel; *P<0.05 vs. CTL; n=3 independent experiments). Kidney International 2013 84, 308-316DOI: (10.1038/ki.2013.97) Copyright © 2013 International Society of Nephrology Terms and Conditions

Figure 7 Proposed scheme: chronic kidney disease (CKD)-induced stimulation of signal regulatory protein-α (SIRP-α) impairs insulin signaling and induces muscle wasting. CKD-induced cytokines stimulate nuclear factor (NF)-κB activation, allowing for increased expression of SIRP-α proteins. Stimulation of SIRP-α triggers tyrosine dephosphorylation of insulin receptor substrate-1 (IRS-1) and insulin receptor (IR), leading to a reduction in p-Akt and finally muscle protein loss. Kidney International 2013 84, 308-316DOI: (10.1038/ki.2013.97) Copyright © 2013 International Society of Nephrology Terms and Conditions